Omnicell Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
Omnicell Stock Forecast and Price Target
Given the average yearlong price target of $38.00 provided by eight prominent analysts over the past few months, there is a potential upside of approximately 36.4% from the last closing price in April, 2024 for Omnicell's stock if it is reached. This estimation is based on a high estimate of $40.00 and a low estimate of $26.00. If you are looking to invest in the stock, it's important to research and compare different companies.
36.40% Upside
Omnicell Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Omnicell's Price has decreased by 100.00%, from $79.10 to $0.00. The next year looks promising for Omnicell, with analysts predicting Fair Value of $54.18 – an increase of 100.00%. Over the next eight years, experts anticipate that Omnicell's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MSFT Stock Forecast | Microsoft Corp | Buy |
18
|
$406.32 | Buy/Sell | $465.63 | 17.19% |
ORCL Stock Forecast | Oracle Corp | Outperform |
13
|
$117.21 | Buy/Sell | $124.26 | 22.86% |
SAP Stock Forecast | SAP | Outperform |
14
|
174.00€ | Buy/Sell | 171.58€ | 12.07% |
IBM Stock Forecast | International Business Machine... | Hold |
7
|
$167.13 | Buy/Sell | $175.67 | 12.19% |
CVS Stock Forecast | CVS Health | Outperform |
12
|
$67.18 | Buy/Sell | $89.54 | 29.95% |
Omnicell Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Omnicell's Revenue has grown, increasing from $892.21M to $1.15B – a growth of 28.57%. For the next year, 8 analysts project Omnicell's Revenue to drop by 5.09%, reaching $1.09B. Over the next ten years, experts anticipate that Omnicell's Revenue will grow at a rate of 53.41%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
PHIA Stock Forecast | Koninklijke Philips N.V. | Hold |
18
|
19.75€ | Buy/Sell | 19.42€ | -1.27% |
MANH Stock Forecast | Manhattan Associates | Outperform |
16
|
$209.02 | Buy/Sell | $214.81 | 14.82% |
GRF Stock Forecast | Grifols | Outperform |
18
|
8.39€ | Buy/Sell | 18.48€ | 126.46% |
Omnicell EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Omnicell's EBITDA has seen a drop from $89.95M to $37.09M – a 58.77% decrease. For next year, analysts predict EBITDA of $133.94M, which would mean an increase of 261.12%. Over the next nine years, experts predict that Omnicell's EBITDA will grow at a rate of 281.49%.
Omnicell EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Omnicell's EBIT has gone down from $51.99M to $-21.53M – a 141.41% drop. In the next year, 7 analysts estimate that Omnicell's EBIT will decrease by 427.45%, reaching $70.50M. According to professional forecasts, in 2030, Omnicell's EBIT will decrease by 410.65%, reaching $66.88M.
Omnicell EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Omnicell's EPS has decreased by 100.00%, from $2.54 to $0.00. The next year looks promising for Omnicell, with analysts predicting EPS of $1.74 – an increase of 100.00%. Over the next eight years, experts anticipate that Omnicell's EPS will grow at a rate of 100.00%.